MRK vs WMT: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Walmart Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
VS
Walmart Inc. · Consumer Defensive
$117.18
-39.6% upside to fair value
Grade C
High Quality
QuantHub Verdict
MRK has more upside to fair value
(-12.1%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
WMT |
| Current Price |
$113.87 |
$117.18 |
| Fair Value Estimate |
$100.14 |
$70.81 |
| Upside to Fair Value |
-12.1%
|
-39.6%
|
| Market Cap |
$281.2B |
$932.5B |
| Forward P/E |
32.0x
|
41.1x
|
| EV / EBITDA |
17.3x
|
20.7x
|
| Price / Sales |
4.3x
|
1.3x
|
| Price / FCF |
19.9x
|
74.3x
|
| Revenue Growth YoY |
+4.3%
|
+7.3%
|
| Gross Margin |
75.9%
|
25.0%
|
| Operating Margin |
27.6%
|
4.2%
|
| Return on Equity |
17.9%
|
24.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.02%
|
1.35%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Walmart Inc. operates as a leading discount retailer with a strong competitive moat built on scale, cost leadership, and advanced logistics and technology infrastructure. The company benefits from a diversified revenue base with Walmart U.S. contributing 69%, International 18%, and Sam's Club 13%. Despite solid revenue growth of 7.3% and earnings growth of 25.9% in the most recent quarter, the st…
Accumulation Zones
| Metric |
MRK |
WMT |
| Zone Low |
$75.11 |
$53.11 |
| Zone High |
$85.12 |
$60.19 |
| In Buy Zone? |
No
|
No
|